BROMOBUTANE LINAGLIPTIN
UNII AT9P8ZQT6X

Substance Identification & Data

This profile provides standardized clinical and technical data for Bromobutane Linagliptin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AT9P8ZQT6X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1638744-06-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

AT9P8ZQT6X

CAS Registry Number

1638744-06-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BROMOBUTANE LINAGLIPTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C25H29BrN8O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

KOVUTSTYXMWMHQ-XBNGYDHASA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

124201672

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(/C=C(\Br)/C)n1c2c(nc1N3C[C@H](N)CCC3)n(C)c(=O)n(Cc4nc5c(c(C)n4)cccc5)c2=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bromobutane Linagliptin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.